Genomically Silent Refractory Gastric Cancer in a Young Patient Exhibits Overexpression of CXCL5
Gastric cancer is the third leading cause of cancer-related deaths, with more than one million new cases and approximately 841,000 deaths annually worldwide. We report a case of a young patient (25 years old) with an aggressive form of gastric cancer. The patient had previously been treated for <...
Main Authors: | Jonathan Hernandez, Michael A. Turner, Prerna Bali, Mojgan Hosseini, Michael Bouvet, Kaitlyn Kelly, Marygorret Obonyo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/29/7/375 |
Similar Items
-
A Bioluminescence-Based Drug Screen Identifies Activities of Fexinidazole and Its Metabolites against <i>Helicobacter pylori</i>
by: Abdolhakim Mohamed, et al.
Published: (2022-11-01) -
Microbiome Signatures in a Fast- and Slow-Progressing Gastric Cancer Murine Model and Their Contribution to Gastric Carcinogenesis
by: Prerna Bali, et al.
Published: (2021-01-01) -
Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw, Poland
by: Tadeusz Tacikowski, et al.
Published: (2017-05-01) -
CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
by: Xin Yu, et al.
Published: (2022-11-01) -
Accuracy of rapid urease test in diagnosing <i>Helicobacter pylori</i> infection in patients using NSAIDs
by: Foroutan Mojgan, et al.
Published: (2010-01-01)